Use of an extracellular matrix material as a vaccine carrier and adjuvant.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Anticancer Research

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 19035274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Baculovirus as an expression and/or delivery vehicle for vaccine antigens

  2008cited by this paper
• Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.

  2008cited by this paper
• Phase 1/2 dose‐escalation study of a GM‐CSF‐secreting, allogeneic, cellular immunotherapy for metastatic hormone‐refractory prostate cancer

  2008cited by this paper
• The potential of topical DNA vaccines adjuvanted by cytokines

  2007cited by this paper
• Tissue vaccines for cancer

  2007cited by this paper
• Immunostimulatory DNA as a vaccine adjuvant

  2007cited by this paper
• Smart adjuvants

  2007cited by this paper
• Bioprosthetic plugs for complex anal fistulas: an early experience.

  2007cited by this paper
• Prevention of human PC-346C prostate cancer growth in mice by a xenogeneic tissue vaccine

  2007cited by this paper
• Effects of sterilization on an extracellular matrix scaffold: Part I. Composition and matrix architecture

  2007cited by this paper
• A comparative analysis of expanded polytetrafluoroethylene and small intestinal submucosa--implications for patch repair in ventral herniorrhaphy.

  2007cited by this paper
• Phase I/II Trial of an Allogeneic Cellular Immunotherapy in Hormone-Naïve Prostate Cancer

  2006cited by this paper
• Hormone-Refractory Prostate Cancer in the Lobund-Wistar Rat

  2005cited by this paper
• Genes Associated with Fast Glioma Cell Migration In Vitro and In Vivo

  2005cited by this paper
• Analysis of Tumor-Host Interactions by Gene Expression Profiling of Lung Adenocarcinoma Xenografts Identifies Genes Involved in Tumor Formation

  2005cited by this paper
• Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial.

  2005cited by this paper
• Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.

  2005cited by this paper
• Prevention of de novo prostate cancer by immunization with tumor-derived vaccines

  2005cited by this paper
• Aluminium adjuvants--in retrospect and prospect.

  2004cited by this paper
• Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen‐independent prostate cancer: A phase 2 trial

  2004cited by this paper
• Small intestinal submucosa does not promote PAIII tumor growth in Lobund-Wistar rats.

  2004cited by this paper
• Transforming growth factor-beta1 in a sterilized tissue derived from the pig small intestine submucosa.

  2003cited by this paper
• Hormone-refractory prostate cancer in the Lobund-Wistar rat.

  2003cited by this paper
• Matrix-dependent plasticity of the malignant phenotype of bladder cancer cells.

  2003cited by this paper
• A model for 3-dimensional growth of bladder cancers to investigate cell-matrix interactions.

  2003cited by this paper
• Human Helper T Cell Activation and Differentiation Is Suppressed by Porcine Small Intestinal Submucosa

  2002cited by this paper
• The Th2-Restricted Immune Response to Xenogeneic Small Intestinal Submucosa Does Not Influence Systemic Protective Immunity to Viral and Bacterial Pathogens

  2002cited by this paper
• Three-dimensional extracellular matrix substrates for cell culture.

  2001cited by this paper
• Cancer Statistics, 2001

  2001cited by this paper
• Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines

  2001cited by this paper
• Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

  2000cited by this paper
• Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells.

  2000cited by this paper
• Small intestinal submucosa: a substrate for in vitro cell growth.

  1998cited by this paper
• Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models.

  1996cited by this paper
• Oral immunization of rabbits against Pasteurella multocida with an alginate microsphere delivery system.

  1996cited by this paper
• Intestine submucosa and polypropylene mesh for abdominal wall repair in dogs.

  1996cited by this paper
• Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion

  1995cited by this paper
• Stability of phenotypic and genotypic traits during the establishment of a human neuroblastoma cell line, IGR‐N‐835

  1989cited by this paper
• How does the extracellular matrix direct gene expression?

  1982cited by this paper
• Transplantable metastasizing prostate adenocarcinomas in rats.

  1975cited by this paper

• Targeting tumor extracellular matrix with nanoparticles to circumvent therapeutic resistance.

  2025cites this paper
• Extracellular matrix scaffold-assisted tumor vaccines induce tumor regression and long-term immune memory

  2023cites this paper
• Use of Conditioned Extracellular Matrix as a Tissue-engineered Tumor Matrisome for Prostate Cancer and Melanoma Immunotherapy

  2022cites this paper
• Decellularization of Small Intestinal Submucosa.

  2021cites this paper
• Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study

  2020cites this paper
• Safety Evaluation of Autologous Tissue Vaccine Cancer Immunotherapy in a Canine Model

  2019cites this paper
• Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell Phenotype

  2019cites this paper
• Cancer vaccines: harnessing the potential of anti-tumor immunity.

  2013cites this paper
• Effects of Small Intestinal Submucosa (SIS) on the Murine Innate Immune Microenvironment Induced by Heat-Killed Staphylococcus aureus

  2012cites this paper
• Immune enhancement by novel vaccine adjuvants in autoimmune-prone NZB/W F1 mice: relative efficacy and safety

  2011cites this paper
• Extracellular Matrix Adjuvant for Vaccines

  2011influential citation
• Extracellular Matrix from Porcine Small Intestinal Submucosa (SIS) as Immune Adjuvants

  2011cites this paper